Wobble modification deficiency in mutant tRNAs in patients with mitochondrial diseases

被引:64
作者
Yasukawa, T
Kirino, Y
Ishii, N
Holt, IJ
Jacobs, HT
Makifuchi, T
Fukuhara, N
Ohta, S
Suzuki, T
Watanabe, K
机构
[1] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan
[2] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bunkyo Ku, Tokyo 1138656, Japan
[3] Nippon Med Coll, Grad Sch Med, Dept Biochem & Cell Biol, Inst Dev & Aging Sci, Kanagawa 2118533, Japan
[4] MRC Dunn Human Nutr Unit, Cambridge CB2 2XY, England
[5] Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland
[6] Univ Tampere, Tampere Univ Hosp, FI-33014 Tampere, Finland
[7] Saigata Natl Hosp, Dept Neuropathol, Ohgata Ku, Niigata 9493193, Japan
[8] Saigata Natl Hosp, Dept Neurol, Ohgata Ku, Niigata 9493193, Japan
基金
英国医学研究理事会;
关键词
mitochondrial disease; mitochondrial tRNA; patient tissue; post-transcriptional modification; taurine;
D O I
10.1016/j.febslet.2005.04.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Point mutations in mitochondrial (mt) tRNA genes are associated with a variety of human mitochondrial diseases. We have shown previously that mt tRNA(Leu(UUR)) with a MELAS A3243G mutation and mt tRNA(Lys) with a MERRF A8344G mutation derived from HeLa background cybrid cells are deficient in normal taurine-containing modifications [tau m(5)(s(2))U; 5-taurinomethyl-(2-thio)uridine] at the anticodon wobble position in both cases. The wobble modification deficiency results in defective translation. We report here wobble modification deficiencies of mutant mt tRNAs from cybrid cells with different nuclear backgrounds, as well as from patient tissues. These findings demonstrate the generality of the wobble modification deficiency in mutant tRNAs in MELAS and MERRF. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2948 / 2952
页数:5
相关论文
共 35 条
[1]  
BJORK GR, 1995, TRNA STRUCTURE BIOSY, P165
[2]   INVITRO GENETIC TRANSFER OF PROTEIN-SYNTHESIS AND RESPIRATION DEFECTS TO MITOCHONDRIAL DNA-LESS CELLS WITH MYOPATHY-PATIENT MITOCHONDRIA [J].
CHOMYN, A ;
MEOLA, G ;
BRESOLIN, N ;
LAI, ST ;
SCARLATO, G ;
ATTARDI, G .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (04) :2236-2244
[3]   MELAS MUTATION IN MTDNA BINDING-SITE FOR TRANSCRIPTION TERMINATION FACTOR CAUSES DEFECTS IN PROTEIN-SYNTHESIS AND IN RESPIRATION BUT NO CHANGE IN LEVELS OF UPSTREAM AND DOWNSTREAM MATURE TRANSCRIPTS [J].
CHOMYN, A ;
MARTINUZZI, A ;
YONEDA, M ;
DAGA, A ;
HURKO, O ;
JOHNS, D ;
LAI, ST ;
NONAKA, I ;
ANGELINI, C ;
ATTARDI, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4221-4225
[5]   DIFFERENT CELLULAR BACKGROUNDS CONFER A MARKED ADVANTAGE TO EITHER MUTANT OR WILD-TYPE MITOCHONDRIAL GENOMES [J].
DUNBAR, DR ;
MOONIE, PA ;
JACOBS, HT ;
HOLT, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) :6562-6566
[6]   Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids [J].
Dunbar, DR ;
Moonie, PA ;
Zeviani, M ;
Holt, IJ .
HUMAN MOLECULAR GENETICS, 1996, 5 (01) :123-129
[7]   Pathophysiology of the MELAS 3243 transition mutation [J].
Flierl, A ;
Reichmann, H ;
Seibel, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :27189-27196
[8]   Human mitochondrial tRNAs in health and disease [J].
Florentz, C ;
Sohm, B ;
Tryoen-Tóth, P ;
Pütz, J ;
Sissler, M .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (07) :1356-1375
[9]   MYOCLONUS EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS (MITOCHONDRIAL ABNORMALITIES) - DISEASE ENTITY OR A SYNDROME - LIGHT-MICROSCOPIC AND ELECTRON-MICROSCOPIC STUDIES OF 2 CASES AND REVIEW OF LITERATURE [J].
FUKUHARA, N ;
TOKIGUCHI, S ;
SHIRAKAWA, K ;
TSUBAKI, T .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1980, 47 (01) :117-133
[10]   A MUTATION IN THE TRANSFER RNALEU(UUR) GENE ASSOCIATED WITH THE MELAS SUBGROUP OF MITOCHONDRIAL ENCEPHALOMYOPATHIES [J].
GOTO, Y ;
NONAKA, I ;
HORAI, S .
NATURE, 1990, 348 (6302) :651-653